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We investigated the response to challenge infection with
Cryptosporidium parvum oocysts in immunosuppressed
C57BL/6N mice. In the primary infection, fecal oocyst
shedding and parasite colonization were greater in
immunosuppressed mice than in nonimmunosuppressed
mice. Compared with primary infection, challenge infection
with  C. parvum didn’t show any oocyst shedding and
parasite colonization. Especially, oocyst shedding and
parasite colonization from the mice infected with heat-
killed oocysts were not detected. After challenge infection
with C. parvum oocysts, however, these mice were shedding
small numbers of oocysts and parasite colonization.
Except normal control and uninfected groups, the antibody
titers of other groups appear similar. Based on the fecal
oocyst shedding, parasite colonization of ilea, and antibody
titers in the mice, these results suggest that the resistance
to challenge infection with C. parvum in immunosuppressed
C57BL/6N mice has increased.
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Introduction
Since the first report of cryptosporidiosis in cattle in 1971
[15], Cryptosporidium parvum has proven to be significantly
important as a cause of neonatal diarrhea in most domesticated
animals [21]. C. parvum (Apicomplexa: Cryptosporididae)
is an intracellular protozoan parasite that colonizes in
epithelial cells of the respiratory and digestive tracts in
humans and other animals [5,11,14]. The most severe
consequence of human cryptosporidiosis occurs in the
immunodeficient host, and C. parvum is recognized as a
significant opportunistic pathogen in the acquired immuno-
deficiency syndrome patient population [14,17]. The infection
is usually mild and self-limiting in hosts with a normal
immune system, but can be chronic and life-threatening in
immunocompromised individuals [3,12]. The prevalence of
C. parvum infections in the general population has
reportedly been 2.2~8.5% [4]. Despite decades of research
on hundreds of chemo- and immunotherapeutic agents
either in vitro or in vivo in animal models and clinical trials,
there is still no specific therapeutic or preventive modality
approved for cryptosporidiosis [22].
In the immune response to C. parvum infection, cell-
mediated and human immune responses are believed to be
involved in the resolution of infections and the development
of protection [19], but the specific immune mechanisms to
C. parvum are not well understood. Cell-mediated immunity
has been suggested to play an important role in clearing
cryptosporidial infections [10]. Especially, CD4
+ T cells and
Interferon (IFN)-γ activity play a major role in immune
system. For example, adult athymic nude mice infected with
C. parvum were reported to develop chronic infections [7]
and IFN-γ seemed to inhibit reproduction of C. parvum in
epithelial cell lines [18]. These results suggest that cell-
mediated immune responses are necessary for both resistance
to and recovery from cryptosporidiosis by C. parvum
oocysts.
Meanwhile, antibody responses to C. parvum antigens,
particularly secretory IgA response to mucosal antigens,
suggest that examination on the local immune response may
be of interest in seroepidemiological studies. Benhamou et
al. [2] reported that Cryptosporidium-infected patients
develop both serum and secretory antibodies to C. parvum.
However, despite the presence of C. parvum-specific serum
and antibodies, infection can persist with protracted diarrhea
in AIDS patients. Thus, cell-mediated immunity has shown
only a limited degree of efficacy in cryptosporidiosis.
The objective of the present study was to investigate the
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Materials and Methods
Animals and parasites
Female C57BL/6N mice (Simonson Laboratories, USA)
aged 6 to 8 weeks weighing 15 to 20 g each were used. The
mice were immunosuppressed with dexamathasone phosphate
(DEXp; Sigma, USA) administered ad libitum in drinking
water (10 µg/ml) [23]. They were maintained in isolation
during the course of the study and were housed in wire-
floored cages. The cages were placed on trays containing
1.8% potassium dichromate solution to prevent the feces
from drying out.
The mice were inoculated with the Iowa isolate of C.
parvum. Oocysts were maintained by passage in experimentally
infected mice and purified from feces using discontinuous
sucrose gradients [1]. Purified oocysts were stored in 2.5%
potassium dichromate solution at 4
oC for less than 4 months
prior to use. Oocyst inocula were prepared by washing
purified oocysts with distilled water 3 times to remove the
potassium dichromate. Washed oocysts were enumerated on
a hemocytometer using microscopy and then administered
to mice by orogastric intubation (10
6 C. parvum oocysts/
mouse) as reported previously [24].
Experimental design
Mice were randomly distributed into six groups of 20
mice/group and housed in different isolation cages. The
mice in groups 1 and 2 were inoculated orogastrically with
10
6 C. parvum oocyst per each on the first day of immuno-
suppression. These mice have received DEXp continuously
until the experiment was terminated. Indeed, on the 25th
day, the mice of group 2 were inoculated with C. parvum
oocysts (secondary infection). Group 3 was inoculated with
heat-killed C. parvum oocysts on the first day of immuno-
suppression. These mice were challenged with C. parvum
oocysts on the 25th day (secondary infection). Groups 4
(positive control) and 5 (negative control) were inoculated
with C. parvum oocysts on the 1st day of the experiment,
but did not receive DEXp. By the way, group 5 was
inoculated with C. parvum oocysts on the 25th day
(secondary infection). Group 6 (normal control) was neither
immuno-suppressed with DEXp nor inoculated with C.
parvum.
Determination of oocyst shedding in infected mice
Fecal pellets were collected from mice in order to monitor
oocyst shedding throughout the experiment at an interval of
5 days. Following collection, the fecal pellets were mixed
with distilled water and one bacterial loop of suspended
material per fecal sample was smeared onto a glass slide.
Monoclonal antibody 9D10, prepared in our laboratory and
specific for oocyst stage of C. parvum, was used in an
indirect immunofluorescent assay (IFA) technique [9]. Smears
were examined microscopically in a blind fashion and
scored 0 to 4+ based on oocyst numbers. Scoring was as
follows; 0, no oocyst detected; 1+, less than 5 oocysts per
smear; 2+, 5 to 50 oocysts per smear; 3+, 50 to 100 oocysts
per smear; and 4+, more than 100 oocysts per smear.
Histologic examinations
Ten mice from each group were killed on the 10th day and
the remaining 10 mice/group were killed on the 40th day.
Tissue samples were collected postmortem from the terminal
ileum. The tissue samples were fixed in 10% formal saline
and embedded in paraffin wax. Sections 4-5 µm in thickness
were cut and stained with hematoxylin and eosin. The tissue
sections were then mounted and examined microscopically
with a 400× objective on a compound microscope. The tissue
samples of randomly selected 10 villi/mouse were examined
and then the number of parasites/epithelial cells on each
villus was counted. The infection was then quantitated by
scoring on a scale of 0 to 3 as follows: 0 = no parasite
observed; 1 = small numbers of parasites focally distributed
in the tissue (less than 10% of the tissue colonized); 2 =
moderate numbers of parasites widely distributed throughout
the tissue (10 to 50% of the tissue colonized); 3 = large
numbers of parasites widely distributed throughout the
tissue (more than 50% of the tissue colonized).
Preparation of parasite homogenate
For antigen preparation, freshly collected oocysts were
purified by sucrose-gradient centrifugation. The purified
oocysts were further purified using a cesium chloride
gradient [8]. These oocysts were sonicated 25 × 50 sec
(50mW) on ice to produce the C. parvum homogenate
(CPH). After homogenization, CPH was subjected to 3
times snap frozen in liquid nitrogen and thawed in a 37
oC
waterbath. CPH prepared in this fashion was assayed for
total protein concentration (Bicinchoninic Acid Protein
Assay; Pierce Scintific, USA) and the final protein
concentration was adjusted to 40-60 µg/ml. CPH was stored
at −20
oC prior to use.
Serum antibody titers
The blood samples were collected from each mouse by
cardiac puncture on the 10th and 40th days. The titer of anti-
C. parvum antibody in the serum was monitored by using a
modified enzyme-linked immunosorbent assay (ELISA) [6].
Briefly, ELISA plates were coated with the oocyst
homogenate of C. parvum in 0.025 M phosphate buffered
saline (pH 7.4) at a concentration of 1 µg protein in 100 µl
per well overnight at 4
oC. The blocked plates were washed
with PBS and a 100 µl of a diluted mouse serum was added.
We used the anti-mouse IgG developed in a rabbit, and
conjugated with horseradish peroxidase for secondary
antibody. Optical density (OD) was read at 450 nm using an
ELISA plate reader (Microplate Autoreader; Bio-Tek,
USA). Serum antibody titers between 10th and 40th dayChallenge infection with C. parvum 49
were analyzed by Student’s t-test in each group. The
p < 0.05 was considered as statistically significant.
Results
One mouse in group 1, 2, and 3 died prior to the end of the
experiment, undoubtedly due to the toxic effects of DEXp.
Other mice in group 1, 2, and 3 exhibited poor health and
hair loss. However, the mice in group 4, 5, and 6 all appeared
healthy and active.
Fecal oocyst detection
The observed oocyst shedding patterns of all groups
appear in Table 1. Oocyst shedding began initially after 5
days’ postinoculation(PI) in group 1, 2, 4, and 5. The mice
in group 3 were inoculated with heat-killed oocysts. Group 6
was served as normal control. All mice in group 1 and 2
were shedding oocysts throughout the duration the 40-day
experiment. Oocyst shedding intensities between group 1
and 2 were very similar on the 5th to 25th days. Group 3 did
not shed oocysts until the 25th day. The mice in group 2 and
3 were infected with C. parvum oocysts on the 25th day. The
intensities of oocyst shedding were significantly greater in
group 1 than in group 2, and 3 from the 30th through 40th
day. Group 4 and 5 inconsistently shed lower numbers of
oocysts until the 10th day.
Histologic examination of terminal ileum
Ten mice from all groups were euthanized by carbon
dioxide inhalation on the 10th and 40th day after the
infection. Parasite colonization in the terminal ilea of mice
from all groups is provided in Table 2. C. parvum colonization
of the terminal ilea of all groups showed similar pattern to
that of the oocyst shedding. The largest number of crypto-
sporidia was found in group 1. Group 4 and 5 inconsistently
shed lower numbers of oocysts until the 10th day, and from
these groups developmental stages of C. parvum were
observed at the 40th day. No parasites were detected in
group 6.
Serum antibody titers
ELISA titers of all groups are graphically illustrated in
Fig. 1. The blood of normal control (group 6) showed a very
low titer and was considered to be negative (range: 0.16~
0.22). The groups inoculated with C. parvum oocysts were
revealed positive titers (range: 0.27~0.42). The mice
inoculated with heat-killed oocysts (group 3) also had
positive antibody titers. In addition, these antibody titers
were similar to each other. The antibody titers of all groups
were higher on the 40th day than on the 10th day except
normal control.
Discussion
The apicomplexan parasite Cryptopsporidium parvum
infects the intestinal tract in humans, calves and other
agriculturally important animals and is a leading cause of
diarrhea throughout the world [20]. However, despite
decades of researches on hundreds of chemo- and immuno-
therapeutic agents either in vitro or in vivo in animal models
and clinical trials, there is no specific therapeutic or
preventive modality approved for cryptosporidiosis [22].
Passive immunization with bovine hyperimmune colostrums
or monoclonal antibodies has been used for the treatment of
cryptosporidiosis in both animals and humans [16].
Table 1. Patterns of Cryptosporidium parvum oocysts shedding
intensity in the mice of all groups
D a y s 5 1 01 52 02 53 03 54 0
G1 4+ 4+ 3+ 4+ 3+ 4+ 4+ 3+
G2 4+ 3+ 4+ 4+ 3+ 2+ 2+ 1+
G 3 00000 1 + 2 + 1 +
G 4 1 + 2 + 000000
G 5 1 + 1 + 000000
G 6 00000000
*Scoring was as follows; 0, no oocyst detected; 1+, less than 5 oocysts
per smear; 2+, 5 to 50 oocysts per smear; 3+, 50 to 100 oocysts per
smear; and 4+, more than 100 oocysts per smear.
Table 2. Parasite colonization of the terminal ileum in the mice
of all groups
Group G1 G2 G3 G4 G5 G6
10th day 3 3 0 1 1 0
40th day 3 2 1 0 0 0
*The index of infection was determined as follows: 0: no parasite
observed; 1: small numbers of parasites focally distributed in the tissue
(less than 10% of the tissue colonized); 2: moderate numbers of parasites
widely distributed throughout the tissue (10 to 50% of the tissue
colonized); 3: large numbers of parasites widely distributed throughout
the tissue (more than 50% of the tissue colonized).
Fig. 1. Patterns of antibody response for sera from the mice of all
groups as detected by ELISA. Data are presented the mean ± SD.
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The objective of the present study was to investigate the
effect of challenge infection with C. parvum oocysts in
immunosuppressed C57BL/6N mice. The oocysts from the
groups of primary infection were detected on the 5th day,
although the intensities of oocyst shedding were significantly
greater in the immunosuppressed mice than in the nonimmuno-
suppressed one. The nonimmunosuppressed mice stopped
shedding after 10 days’ PI, whereas the group of immuno-
suppressed mice continued to shed oocysts through the
experimental period. Especially, despite the reinfection of C.
parvum oocysts in the negative control group, oocysts were
not detected in the mice. The heat-killed oocyst inoculation
group did not shed oocysts until the 25th day. These mice
were shedding oocysts from the 30th to 40th day. In addition
the amount of shedding oocysts in the immunosuppressed
mice of primary and secondary infection group, and heat-
killed oocyst inoculation group was very similar to each
other after secondary infection. The mice of normal control
did not shed oocysts. These results indicate that dead and
live oocysts of C. parvum have protective effect against C.
parvum infection. Although challenge infection has resulted
in reduction of oocyst shedding, it did not truly eliminate the
infection.
Through microscopic examination of tissue sections, it was
revealed that C. parvum was localized predominantly in the
small intestines. Specifically, the greatest levels of parasites
were located in terminal ileum [19]. In the present study,
parasite colonization of all groups except normal control was
observed to have the same pattern of fecal oocyst shedding.
The diagnosis of cryptosporidiosis is commonly done by
microscopic detection of oocysts in feces, but this method is
relatively slow, subject to the expertise of the microscopist,
and thus is often not cost effective. The serological study by
ELISA had a high sensitivity and low specificity [13]. In the
present study, the infection of C. parvum was investigated
by using an ELISA technique. Antibody titers of the primary
infection group were very similar each other. Indeed, the
mice inoculated with heat-killed oocysts revealed positive
titers. Especially, the titers of the heat-killed oocyst inoculation
group were not different from other groups. Furthermore,
the ELISA titers of these groups were higher on the 40th day
than on the 10th day. These results indicate that the C.
parvum and the whole C. parvum extracts have a moderate
protection against the reinfection. Thus, these results
demonstrate that the adult C57BL/6N mice infected with C.
parvum is more resistant to a challenge infection following
immunosuppression with DEXp as determined by decreased
fecal oocyst shedding, reduced parasite colonization of the
ilea and increased serum antibody titers.
Meanwhile, nonimmunosuppressed mice with primary
infection have acquired identical levels of immunity to C.
parvum throughout experimental period regardless of challenge
infection, and it seems that mice with primary infection have
acquired high immunity.
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